Company Encyclopedia
View More
name
CVS Health
CVS.US
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.
380.10 B
CVS.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Health Care ServicesIndustry
Industry Ranking22/79
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE0.63%D
    • Profit Margin0.12%D
    • Gross Margin12.89%D
  • Growth ScoreC
    • Revenue YoY6.66%C
    • Net Profit YoY-90.65%E
    • Total Assets YoY1.15%C
    • Net Assets YoY-2.66%D
  • Cash ScoreB
    • Cash Flow Margin83515.99%A
    • OCF YoY6.66%C
  • Operating ScoreA
    • Turnover1.54A
  • Debt ScoreD
    • Gearing Ratio71.37%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More
    Posts
    View More

    $Eli Lilly(LLY.US) -4.8% premarket after it cut its profit forecast for FY’25 EPS and CVS Health announced plans to move Lilly’s weight-loss drug, Zepbound, off its list of preferred drugs. Lilly repo...

    .............................................